Next-Gen Access SolutionsLower-cost Rx access, without the blind spots
The old pharmacy model wasn’t built for today’s access options. Expion helps organizations evaluate the latest access and affordability pathways and connect them to broader pharmacy, formulary, and financial strategies.
New access pathways are changing the Rx value equation
New access pathways can create better routes to affordable therapy, but they also make pharmacy strategy harder to manage when claims, vendors and member behavior move outside the standard benefit view.
The challenge is knowing which pathways create real value for the plan and the member. Organizations need to evaluate whether a pathway lowers net cost, supports affordability and adherence, fits the population, reinforces formulary strategy and can be operationalized without creating new blind spots.
Turn access options into a savings strategy
The growing number of affordability and access programs creates opportunity—but also complexity.
Expion Health® helps organizations determine which options create value, how they fit within the benefit, and how to measure their impact over time.
Independent by Design
Evaluate access options across vendors, models and pathways instead of locking strategy around a single solution.
Connected to Your Rx Strategy
Bring alternative access into the broader pharmacy strategy, so savings opportunities don’t become off-benefit blind spots.
Built for Member Action
Reduce access and affordability barriers and help members access programs designed to support real-world adoption and adherence.
Value You Can Measure
Track engagement, utilization and outcomes so teams can understand what worked, what changed and what should happen next.
Better access can change the cost equation
The future of prescription access won’t be defined by a single pathway. Expion helps organizations evaluate and operationalize emerging affordability and access models while keeping clinical care, member experience, pharmacy performance, and long-term strategy connected.
Access pathways organizations are increasingly evaluating:
Find savings a traditional Rx benefit misses
Emerging access models can reveal savings and affordability opportunities that traditional benefit designs often overlook.
A few examples of what those pathways can uncover:
[Drug Name] Savings Opportunity
Traditional Benefit Cost: $X
Alternative Access Cost: $X
Potential Savings: $X
[Drug Name] Savings Opportunity
Traditional Benefit Cost: $X
Alternative Access Cost: $X
Potential Savings: $X
[Drug Name] Savings Opportunity
Traditional Benefit Cost: $X
Alternative Access Cost: $X
Potential Savings: $X
*Examples are illustrative and based on past client opportunities; actual results vary by drug, plan design, population and available access pathway.
Keep every access move tied to the full Rx equation
New access pathways create more value when they stay connected to the strategy around them.
Our modular approach connects access, formulary strategy, member affordability and ExpionIQ® intelligence so every access move builds on your strategy.
Total Value Formularies
Build formulary strategies around the full value equation, including cost, clinical alignment, access, rebates and long-term performance.
Member Affordability Solutions
Design affordability strategies that help reduce member cost barriers while strengthening pharmacy benefit performance.
The intelligence behind every modular move
ExpionIQ® powers the data, intelligence and activation behind Next-Gen Access Solutions, helping teams identify where emerging access pathways create value, support targeted engagement and keep every claim visible, no matter where it's filled.
The next pharmacy playbook is already being written
Get the Expion perspective on the trends, decisions, and market shifts redefining how pharmacy value is created.
Bring new Rx savings pathways into view
Discover where alternative access could fit in your current pharmacy strategy, which savings opportunities are worth evaluating and how to act on them without losing sight of the broader benefit.